(S (PP (IN As) (NP (DT a) (ADJP (RB highly) (JJ infectious)) (NN respiratory) (NN disease))) (, ,) (NP (NNP COVID-19)) (VP (VBZ has) (VP (VBN become) (NP (NP (DT a) (JJ pandemic)) (SBAR (WHNP (IN that)) (S (VP (VBZ threatens) (NP (JJ global) (NN health)))))))) (. .))
(S (PP (IN Without) (NP (DT an) (JJ effective) (NN treatment))) (, ,) (NP (NP (JJ non-pharmaceutical) (NNS interventions)) (, ,) (PP (JJ such) (IN as) (NP (NN travel) (NNS restrictions))) (, ,)) (VP (VBP have) (VP (VBN been) (VP (ADVP (RB widely)) (VBN promoted) (S (VP (TO to) (VP (VB mitigate) (NP (DT the) (NN outbreak)))))))) (. .))
(S (S (NP (JJ Current) (NNS studies)) (VP (VBP analyze) (NP (NP (NN mobility) (NNS metrics)) (PP (JJ such) (IN as) (NP (NN travel) (NN distance)))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (NN lack)) (PP (IN of) (NP (NP (NN research)) (PP (IN on) (NP (NP (JJ interzonal) (NN travel) (NN flow)) (CC and) (NP (NP (PRP$ its) (NN impact)) (PP (IN on) (NP (DT the) (NN pandemic))))))))))) (. .))
(S (NP (PRP$ Our) (NN study)) (ADVP (RB specifically)) (VP (VBZ focuses) (PP (IN on) (NP (NP (DT the) (JJ inter-county) (NN mobility) (NN pattern)) (CC and) (NP (NP (PRP$ its) (NN influence)) (PP (IN on) (NP (NP (DT the) (NNP COVID-19) (NN spread)) (PP (IN in) (NP (DT the) (NNP United) (NNPS States))))))))) (. .))
(S (S (VP (TO To) (VP (VB retrieve) (NP (NN real-world) (NN mobility) (NNS patterns))))) (, ,) (NP (PRP we)) (VP (VBP utilize) (NP (NP (DT an) (JJ integrated) (NN set)) (PP (IN of) (NP (JJ mobile) (NN device) (NN location) (NNS data))) (PP (VBG including) (NP (QP (IN over) (CD 100) (CD million)) (JJ anonymous) (NNS devices))))) (. .))
(S (NP (PRP We)) (ADVP (RB first)) (VP (VB investigate) (NP (NP (DT the) (NX (NX (JJ nationwide) (NX (JJ temporal) (NN trend))) (CC and) (NX (JJ spatial) (NN distribution)))) (PP (IN of) (NP (JJ inter-county) (NN mobility))))) (. .))
(S (ADVP (RB Then)) (NP (PRP we)) (VP (VP (VBP zoom) (PRT (IN in)) (PP (IN on) (NP (NP (NP (DT the) (NN epicenter)) (PP (IN of) (NP (DT the) (NNP U.S.) (NN outbreak)))) (, ,) (NP (NNP New) (NNP York) (NNP City)) (, ,)))) (CC and) (VP (VB evaluate) (NP (NP (DT the) (NNS impacts)) (PP (IN of) (NP (PRP$ its) (NN outflow))) (PP (IN on) (NP (JJ other) (NNS counties)))))) (. .))
(S (ADVP (RB Finally)) (, ,) (NP (PRP we)) (VP (VBP develop) (NP (DT a) (`` ``) (JJ log-linear) (NN double-risk) ('' '') (NN model)) (PP (IN at) (NP (DT the) (NN county) (NN level))) (S (VP (TO to) (VP (VB quantify) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (DT both) (NP (`` ``) (JJ external) (NN risk) ('' '') (VP (VBN imported) (PP (IN by) (NP (JJ inter-county) (NN mobility) (NNS flows))))) (CC and) (NP (NP (DT the) (`` ``) (JJ internal) (NN risk) ('' '')) (VP (VBN defined) (PP (IN as) (NP (NP (DT the) (NN vulnerability)) (PP (IN of) (NP (DT a) (NN county))) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (NN population)) (PP (IN with) (NP (JJ high-risk) (NNS phenotypes)))))))))))))))))) (. .))
(S (NP (PRP$ Our) (NN study)) (VP (VP (VBZ enhances) (NP (NP (DT the) (NN situation) (NN awareness)) (PP (IN of) (NP (NP (JJ inter-county) (NN mobility)) (PP (IN in) (NP (DT the) (NNP U.S.))))))) (CC and) (VP (MD can) (VP (VB help) (S (VP (VB improve) (NP (NP (JJ non-pharmaceutical) (NNS interventions)) (PP (IN for) (NP (NNP COVID-19))))))))) (. .))
